These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18852449)

  • 1. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Troiano AR; Cazeneuve C; Le Ber I; Bonnet AM; Lesage S; Brice A
    Neurology; 2008 Oct; 71(16):1295; author reply 1295. PubMed ID: 18852449
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Brueggemann N; Odin P; Gruenewald A; Tadic V; Hagenah J; Seidel G; Lohmann K; Klein C; Djarmati A
    Neurology; 2008 Oct; 71(16):1294; author reply 1294. PubMed ID: 18852448
    [No Abstract]   [Full Text] [Related]  

  • 3. Two Parkinson's disease patients with alpha-synuclein gene duplication and rapid cognitive decline.
    Shin CW; Kim HJ; Park SS; Kim SY; Kim JY; Jeon BS
    Mov Disord; 2010 May; 25(7):957-9. PubMed ID: 20222138
    [No Abstract]   [Full Text] [Related]  

  • 4. alpha-Synuclein gene duplications in sporadic Parkinson disease.
    Theuns J; Van Broeckhoven C
    Neurology; 2008 Jan; 70(1):7-9. PubMed ID: 18166703
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication.
    Orimo S; Uchihara T; Nakamura A; Mori F; Ikeuchi T; Onodera O; Nishizawa M; Ishikawa A; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2008 Nov; 116(5):575-7. PubMed ID: 18751989
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease.
    Deng H; Xie W; Guo Y; Le W; Jankovic J
    Mov Disord; 2006 May; 21(5):728-9. PubMed ID: 16552756
    [No Abstract]   [Full Text] [Related]  

  • 7. The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease.
    Ki CS; Stavrou EF; Davanos N; Lee WY; Chung EJ; Kim JY; Athanassiadou A
    Clin Genet; 2007 May; 71(5):471-3. PubMed ID: 17489854
    [No Abstract]   [Full Text] [Related]  

  • 8. SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.
    Mutez E; Leprêtre F; Le Rhun E; Larvor L; Duflot A; Mouroux V; Kerckaert JP; Figeac M; Dujardin K; Destée A; Chartier-Harlin MC
    Hum Mutat; 2011 Apr; 32(4):E2079-90. PubMed ID: 21412942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical variability in Chinese families with Parkinson disease and SNCA duplication, including the shortest 139kb duplication.
    Du YJ; Shen Y; Wang YX; Sun YM; Liu FT; Chen C; Chen K; Zuo CT; Wu JJ; Wang J; An Y; Yu H
    Parkinsonism Relat Disord; 2019 Nov; 68():60-62. PubMed ID: 31621621
    [No Abstract]   [Full Text] [Related]  

  • 10. The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element.
    Friedlich AL; Tanzi RE; Rogers JT
    Mol Psychiatry; 2007 Mar; 12(3):222-3. PubMed ID: 17325711
    [No Abstract]   [Full Text] [Related]  

  • 11. Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.
    Kao SY
    Biochem Biophys Res Commun; 2009 Jul; 385(3):434-8. PubMed ID: 19470380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful GPi stimulation in genetic Parkinson's disease caused by mosaicism of alpha-synuclein gene duplication: first description.
    Perandones C; Aráoz Olivos N; Raina GB; Pellene LA; Giugni JC; Calvo DS; Radrizzani M; Piedimonte F; Micheli FE
    J Neurol; 2015 Jan; 262(1):222-3. PubMed ID: 25408368
    [No Abstract]   [Full Text] [Related]  

  • 13. Drift diffusion model of reward and punishment learning in rare alpha-synuclein gene carriers.
    Moustafa AA; Kéri S; Polner B; White C
    J Neurogenet; 2017; 31(1-2):17-22. PubMed ID: 28316265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor on "Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals".
    Hamilton BA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1154. PubMed ID: 19903454
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia.
    Obi T; Nishioka K; Ross OA; Terada T; Yamazaki K; Sugiura A; Takanashi M; Mizoguchi K; Mori H; Mizuno Y; Hattori N
    Neurology; 2008 Jan; 70(3):238-41. PubMed ID: 18195271
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?
    Puschmann A; Wszolek ZK; Farrer M; Gustafson L; Widner H; Nilsson C
    Parkinsonism Relat Disord; 2009 Jun; 15(5):390-2. PubMed ID: 18824390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics and molecular biology of alpha-synuclein.
    Farrer M
    Handb Clin Neurol; 2008; 89():313-9. PubMed ID: 18631756
    [No Abstract]   [Full Text] [Related]  

  • 20. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.